참고문헌
- Hitz F, Bargetzi M, Coqliatti S, Lohri A, Taverna C, Renner C, et al. Diagnosis and treatment of mantle cell lymphoma. Swiss Med Wkly. 2013 Nov 13;143:w13868. Available from: URL:http://www.smw.ch/content/smw-2013-13868.
- Ambinder AJ, Shenoy PJ, Nastoupil LJ, Flowers CR. Using primary site as a predictor of survival in mantle cell lymphoma. Cancer. 2013;119(8):1570-1577. https://doi.org/10.1002/cncr.27898
- Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD. Mantle cell lymphoma: A clinicopathologic study of 80 cases. Blood. 1997;89(6):2067-2078. https://doi.org/10.1182/blood.V89.6.2067
- Pilavaki M, Athanasiadou A, Iordanidis F, Karakozoglou T, Palladas P. Magnetic resonance imaging with pathological correlation in a case of mantle cell lymphoma of the parotid gland: A case report. J Med Case Rep. 2010 Mar 30;4:99. Available from: URL: http://www.jmedicalcasereports.com/content/4/1/99. https://doi.org/10.1186/1752-1947-4-99
- Yamada T, Goto N, Tsurumi H, Takata K, Sato Y, Yopshino T, et al. Mantle cell lymphoma with a unique pattern of CD5 expression: A case report with review of the literatures. Med Mol Morphol. 2014;47(3):169-175. https://doi.org/10.1007/s00795-013-0060-x
- Pileri SA, Falini B. Mantle cell lymphoma. Haematologica. 2009;94(11):1488-1492. https://doi.org/10.3324/haematol.2009.013359
- Park JB, Kwon JG, Oh JY, Han JM, Jung JT, Kim EY, et al. A case of mantle cell lymphoma presenting as a small intestinal stricture. Intest Res. 2012;10(3):300-304. https://doi.org/10.5217/ir.2012.10.3.300
- Nodit L, Bahler DW, Jacobs SA, Locker J, Swerdlow SH. Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes. Hum Pathol. 2003;34(10):1030-1034. https://doi.org/10.1053/S0046-8177(03)00410-6
- Orchard J, Garand R, Davis Z, Babbage G, Sahota S, Matutes E, et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, non-nodal disease. Blood. 2003 15;101(12):4975-4981. https://doi.org/10.1182/blood-2002-06-1864
- Ambinder AJ, Shenoy PJ, Nastoupil LJ, Flowers CR. Using primary site as a predictor of survival in mantle cell lymphoma. Cancer. 2013;119(8):1570-1577. https://doi.org/10.1002/cncr.27898
- Lai R, Medeiros LJ. Pathologic diagnosis of mantle cell lymphoma. Clin lymphoma. 2010;1(3):197-206.
- Hwang JY, Kim SW, Yang SC, Kim CD. Extraparotid warthin tumor in upper cervical lymph node accompanied by primary cervical tuberculosis. Otolaryngol Head Neck Surg. 2011;144(4):646-647. https://doi.org/10.1177/0194599811398187
- Choi KM, Yang SC, Kim SW. Two cases of extraparotid Warthin's tumor in lateral cervical region. Korean J Head Neck Oncol. 2010;26(2):232-235.
- Rajguru S, Kahl BS. Emerging therapy for the treatment of mantle cell lymphoma. J Natl Compr Canc Netw. 2014;12(9):1311-1318. https://doi.org/10.6004/jnccn.2014.0126
- Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, et al. A new prognostic index(MIPI) for patients with advanced-stage mantle cell lymphoma. Blood. 2008;111(2):558-565. https://doi.org/10.1182/blood-2007-06-095331
- Geisler CH, Kolstad A, Laurell A, Raty R, Jerkeman M, Eriksson M, et al. The Mantle cell lymphoma International Prognostic Index(MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT). Blood. 2010;115(8):1530-1533. https://doi.org/10.1182/blood-2009-08-236570